Clinical trial
Open-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by…
NCT00115128 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00115128 |
|---|---|
| Title | Open-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim in Normal Donors |
| Official title | Open-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim in Normal Donors |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Normal PBPC Donors |
| Intervention type | Drug |
| Interventions | filgrastim |
| Enrollment | 309 |
| Start date | Nov 1, 2003 |
| Primary completion | May 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Jun 22, 2005 |
| Last update posted | May 13, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: